Phocas Financial Corp’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-60,408
Closed -$5.34M – 256
2015
Q1
$5.34M Sell
60,408
-32,824
-35% -$2.91M 0.42% 110
2014
Q4
$7.74M Sell
93,232
-2,616
-3% -$217K 0.67% 46
2014
Q3
$8.08M Sell
95,848
-283
-0.3% -$22.9K 0.72% 37
2014
Q2
$7.8M Sell
96,131
-3,798
-4% -$299K 0.68% 53
2014
Q1
$7.61M Sell
99,929
-1,870
-2% -$136K 0.73% 42
2013
Q4
$7.33M Sell
101,799
-13,744
-12% -$955K 0.68% 46
2013
Q3
$7.94M Buy
115,543
+43,201
+60% +$2.86M 0.76% 37
2013
Q2
$4.58M Buy
+72,342
New +$4.71M 0.48% 86

Other funds holding NVS

Phocas Financial Corp's NVS Position: Q2 2015 in Review

Phocas Financial Corp sold out of Novartis (NVS) in Q2 2015, closing a stake of 60,408 shares — an estimated $5.34M sold.

Phocas Financial Corp first reported a position in NVS in Q2 2013 and held it in 8 quarters. The position peaked at $8.08M in Q3 2014. 945 funds tracked by Wall St. Rank hold NVS as of Q2 2015.

  • Phocas Financial Corp reported no remaining Novartis position as of Q2 2015 after selling out during the quarter.
  • Phocas Financial Corp sold 60,408 Novartis shares in Q2 2015, an estimated $5.34M.
  • Phocas Financial Corp first reported a position in Novartis in Q2 2013 and held it in 8 quarters.
  • Phocas Financial Corp's Novartis position peaked at $8.08M in Q3 2014.
  • 945 funds tracked by Wall St. Rank held Novartis as of Q2 2015.

Based on Phocas Financial Corp's 13F filing for Q2 2015, filed 12 Aug 2015.